Philips Pushes Further Into AI Diagnostics After Regulatory Agreements
Royal Philips is continuing its shift toward healthcare technology and artificial intelligence-based diagnostic imaging after reaching regulatory agreements with the United States Food and Drug Administration, while drawing on European research partnerships to support its recovery.